Medicare Enrolled
Dr. Paul Jo, MD
Optician · Ocala, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jo
Dr. Paul Jo is an optician specialist in Ocala, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Jo performed 29,692 Medicare services across 9,162 unique beneficiaries.
Between the years covered by Open Payments, Dr. Jo received a total of $25,618 from 52 pharmaceutical and/or device companies across 421 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are classified as financial or ownership interests (royalties, licensing fees, or investment interests). Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in FL
$25,618 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 72987 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗29,692
Medicare services
Top 3% in FL for optician
9,162
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,563 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Genetic analysis to identify organisms A laboratory test that uses genetic analysis and an amplified probe technique to identify specific organisms. |
7,980 | $34 | $106 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
3,503 | $2 | $5 |
| Denosumab injection (Prolia/Xgeva) | 2,760 | $19 | $36 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,285 | $64 | $188 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
2,007 | $69 | $210 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
1,330 | $34 | $106 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
1,328 | $34 | $106 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,126 | $94 | $273 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
735 | $8 | $26 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
665 | $34 | $106 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
665 | $34 | $106 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
665 | $34 | $106 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
664 | $34 | $106 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
664 | $34 | $106 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
427 | $62 | $525 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 324 | $134 | $423 |
| Electronic analysis of implanted neurostimulator This procedure involves electronically analyzing an implanted neurostimulator generator and performing simple programming for spinal cord or peripheral nerve stimulation. |
306 | $37 | $323 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
266 | $122 | $415 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
167 | $41 | $107 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
142 | $41 | $2,415 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
124 | $101 | $630 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
108 | $6 | $37 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
107 | $25 | $190 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
102 | $301 | $895 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
102 | $150 | $345 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
101 | $26 | $171 |
| Bladder biopsy using endoscope A procedure to remove a small tissue sample from the bladder using a thin, flexible tube with a camera. The sample is then examined to check for abnormalities. |
99 | $48 | $960 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
95 | $229 | $760 |
| Injection, garamycin, gentamicin, up to 80 mg | 90 | $2 | $4 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
85 | $456 | $1,901 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
70 | $75 | $1,133 |
| Sacral nerve stimulator electrode insertion A procedure to place an electrode array in the sacral area to deliver electrical stimulation to the nerves. |
69 | $276 | $1,878 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
62 | $116 | $733 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
57 | $20 | $50 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
54 | $95 | $335 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
50 | $67 | $213 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
48 | $91 | $738 |
| Insertion of peripheral or gastric neurostimulator generator A surgical procedure to implant the pulse generator device for a neurostimulator system. The generator is placed under the skin to deliver electrical impulses to nerves or the stomach. |
47 | $67 | $673 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
45 | $169 | $3,343 |
| Electronic analysis of implanted neurostimulator with complex programming This procedure involves the electronic evaluation of an implanted neurostimulator generator. It includes complex programming of spinal cord or peripheral nerve stimulators. |
35 | $33 | $363 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
30 | $54 | $488 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
30 | $143 | $368 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $45 | $113 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
19 | $140 | $518 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
15 | $973 | $3,815 |
| Bladder stone removal, larger than 2.5 cm A procedure to crush, fragment, and remove bladder stones that are larger than 2.5 centimeters. |
14 | $361 | $1,253 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
13.7% medium
85.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,618
Total received (2018-2024)
Avg $3,660/year across 7 years
Top 7% in FL for optician
52
Companies
421
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$13,500 (52.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,110 (43.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,008 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,253
2023
$1,640
2022
$3,029
2021
$4,616
2020
$4,390
2019
$4,210
2018
$5,479
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Laser Specialty Medical, LLC
$13,500
Axonics, Inc.
$2,938
Teleflex LLC
$2,388
Astellas Pharma US Inc
$1,629
Coloplast Corp
$614
Medtronic, Inc.
$581
Endo Pharmaceuticals Inc.
$377
Boston Scientific Corporation
$280
Janssen Biotech, Inc.
$264
Dendreon Pharmaceuticals LLC
$248
Amgen Inc.
$196
Medtronic USA, Inc.
$195
UROVANT SCIENCES INC
$187
Myovant Sciences Inc.
$145
Bayer HealthCare Pharmaceuticals Inc.
$132
PROCEPT BioRobotics Corporation
$118
Allergan, Inc.
$113
Acerus Pharmaceuticals Corporation
$112
Allergan Inc.
$106
Janssen Products, LP
$100
PFIZER INC.
$92
Olympus America Inc.
$91
BOSTON SCIENTIFIC CORPORATION
$90
UROGEN PHARMA, INC.
$85
Bayer Healthcare Pharmaceuticals Inc.
$81
Sumitomo Pharma America, Inc.
$78
180 Medical, Inc.
$76
Tolmar, Inc.
$59
C. R. Bard, Inc. & Subsidiaries
$50
Endo USA, Inc.
$50
Verity Pharmaceuticals Inc.
$48
BLUEWIND MEDICAL
$46
Axonics Modulation Technologies, Inc.
$45
AbbVie, Inc.
$44
MEDIVATION FIELD SOLUTIONS LLC
$41
COLOPLAST CORP
$39
UroGen Pharma, Inc.
$38
Rochester Medical Corporation
$36
Baudax Bio Inc.
$36
Metuchen Pharmaceuticals
$33
Merck Sharp & Dohme Corporation
$31
AcelRx Pharmaceuticals, Inc.
$22
Pacira Pharmaceuticals Incorporated
$22
Profound Medical Corp.
$21
Blue Earth Diagnostics Limited
$21
DENTSPLY IH Inc.
$19
ABBVIE INC.
$19
Rigicon,Inc.
$18
Ambu Inc.
$18
Ferring Pharmaceuticals Inc.
$16
Kowa Pharmaceuticals America, Inc.
$16
Lumenis, Inc
$14
Top 3 companies account for 73.5% of total payments
Associated products mentioned in payments ›
ADSTILADRIN · ADVANTAGE FIT · AMS · AMS 700 · ANJESO · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · Bulkamid · DSUVIA · ELIGARD · ERLEADA · Erleada · Exparel · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL - KIDNEY STONE DISEASE · GENERAL BPH · INTERSTIM · JELMYTO · KEYTRUDA · LITHOVUE · LoFric · Lumenis Pulse 120H · Lupron Depot · MYRBETRIQ · Myrbetriq · Natesto · Nubeqa · ORGOVYX · PROVENGE · Porges Coloplast · Prolia · REVI · REZUM · RIGI10 MALLEABLE PENILE PROSTHESIS · ReTrace · SEGLENTIS · SPACEOAR VUE · SPECTRA WAVEWRITER · SUPRIS · SpaceOAR VUE System - 10mL · Stendra · TESTOPEL · TITAN · TOVIAZ · Trelstar · Tulsa-Pro · UROLIFT · UroLift System · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 7% for optician in FL.
Equivalent to $86 per 100 Medicare services performed
Geographic Context
Opticians within 10 mi
78
Per 100K population
20.1
County median income
$58,535
Nearest hospital
MARION COMMUNTIY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Jo is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), with mixed engagement industry engagement in the top 7% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Jo experienced with genetic analysis to identify organisms?
Based on Medicare claims data, Dr. Jo performed 7,980 genetic analysis to identify organisms services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jo receive payments from pharmaceutical companies?
Yes. Dr. Jo received a total of $25,618 from 52 companies across 421 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jo's costs compare to other opticians in Ocala?
Dr. Jo's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Ocala
Browse opticians in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Opticians in FL
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in FL
Which FL opticians receive the most from drug and device companies.
By company
Laser Specialty Medical, LLC Payments to Doctors
See all physicians who received payments from Laser Specialty Medical, LLC.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology